Trepipam
From Wikipedia, the free encyclopedia
Legal status | |
---|---|
Legal status |
|
Identifiers | |
|
|
PubChem (CID) | 5024 |
ChemSpider | 4849 |
Chemical and physical data | |
Formula | C19H23NO2 |
Molar mass | 297.39 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
Trepipam (INN) is a dopamine receptor agonist of the benzazepine group that was never marketed.[1]
References[edit]
- ^ Daniel Lednicer (4 March 2009). Strategies for Organic Drug Synthesis and Design. John Wiley & Sons. pp. 495–. ISBN 978-0-470-39959-0.
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |